Using phase change materials for smart glazing and displays.

Peptide display company identifying potential peptide drugs for a range of chronic diseases

Their system uses electromagnetic and acoustic waves to create a new class of medical images at a cost comparable to ultrasound.

Oxford Flow’s industrial pressure regulators use innovative technology to provide new levels of performance for natural gas transmission, water distribution and process industries.

Nanoparticles for cancer therapy, imaging and drug delivery.

Developing a novel cancer immunotherapy discovered through a collaboration between Ludwig Cancer Research and Professor Vincenzo Cerundolo, the director of the MRC Human Immunology Unit within the University of Oxford’s Weatherall Institute of Molecular Medicine.

Developing domestic energy storage capacity and facilitating its operation within the existing power distribution infrastructure.

Animal Dynamics marries fine-engineering skills with a deep understanding of the fundamental mechanisms, to produce revolutionary machines that will change the shape of the future, taking inspiration from our environment in order to protect it, and capable of performance beyond anything currently found in nature or engineering.

Domain-centric intelligent automated data extraction methodology.

Oxbotica. Robotics, autonomous systems, driverless pods.

Deontics is software which guides doctors and patients through the scientific and clinical decision making.

Developing 3D printing techniques to produce a range of tissue-like and functional tissues for medical research and clinical applications. Their vision is to ultimately produce tissues that can be used in the clinic for organ repair or replacement.

Designer Carbon Materials, Developing advanced nanomaterials for a range of applications, including energy harvesting, bio-sensing and quantum nanoelectronics.

Develop cutting edge software applications that uncover the relationships between genetic variation and human disease.
Help pharmaceutical companies de-risk the drug development process.

OxCept is a team of security and communication experts creating military-grade authentication security products for business teams.

OxSonics provide economic and scalable life-changing treatments to solid tumour cancer patients.

A private biopharmaceutical company focused on the development of therapies for retinal dystrophies. NightStar Therapeutics was acquired by Biogen in June 2019.

A rapidly grown, energetic company specialising in translational and regenerative medicine.

Duchenne Muscular Dystrophy.

Develops and commercialises enzymatic process technologies that yield high-value chemical compounds.